Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
311.14 M USD
0.00 USD
108.65 M
About LianBio
Sector
Industry
CEO
Adam Leo Stone
Website
Headquarters
Princeton
Founded
2019
FIGI
BBG0133N20F9
LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.